Celadon Pharmaceuticals Plc (AIM: CEL)
London
· Delayed Price · Currency is GBP · Price in GBX 23.70
+2.20 (10.23%)
Jan 22, 2025, 11:53 AM GMT+1
Celadon Pharmaceuticals Market Cap
Celadon Pharmaceuticals has a market cap or net worth of 14.80 million as of January 22, 2025. Its market cap has decreased by -77.51% in one year.
Market Cap
14.80M
Enterprise Value
19.59M
Revenue
130.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
23.70
Market Cap Chart
Since March 29, 2022, Celadon Pharmaceuticals's market cap has decreased from 89.42M to 14.80M, a decrease of -83.45%. That is a compound annual growth rate of -47.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2025 | 14.80M | 43.33% |
| Dec 31, 2024 | 10.33M | -86.01% |
| Dec 29, 2023 | 73.84M | 137.10% |
| Dec 30, 2022 | 31.14M | -65.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 167.37B |
| GSK plc | 55.25B |
| Haleon | 33.81B |
| Smith & Nephew | 8.96B |
| ConvaTec Group | 4.94B |
| Hikma Pharmaceuticals | 4.62B |
| HUTCHMED (China) | 1.99B |
| Oxford Nanopore Technologies | 1.42B |